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Abstract 
Aims.-The importance of reducing sedentary-time is increasingly recognized for the 
prevention of diabetes and cardiovascular disease. Despite this, the prospective association 
between sedentary-time and physical activity with insulin sensitivity and cardio-metabolic 
risk factors has been little studied. 
Methods.-We analyzed data from the European RISC study. Sedentary-time and time 
in activity of moderate or vigorous intensity were assessed by accelerometry at baseline in 
313 men and 414 women, 30-60 years, with insulin sensitivity measured by euglycaemic 
hyperinsulinemic clamp. Three years later, cardio-metabolic risk factors (anthropometry, 
glucose, insulin, lipids) were available in 549 participants.  
Results.-In cross-sectional analyses using baseline data, after adjusting for age, gender, 
recruitment centre and time in activity of moderate or vigorous intensity, significant 
unfavorable associations were observed between higher sedentary-time with body weight, 
HDL-cholesterol, triglycerides, clamp-measured insulin sensitivity and insulin secretion (all 
Ptrend<0.002). Sedentary-time remained significantly associated with insulin secretion, after 
adjustment for insulin sensitivity (Ptrend=0.02). In longitudinal analyses, higher baseline 
sedentary-time was associated with 3-year increases in fasting glucose, fasting insulin and the 
HOMA insulin resistance index, for the 50% of our study population who increased their BMI 
by at least 0.3 kg/m² (all Ptrend<0.01); these relations remained significant after adjusting for 
time spent in activity of moderate or vigorous intensity.  The 3-year increase in insulin 
secretion was lower in those spending more time in activity of moderate or vigorous intensity 
(Ptrend=0.03). 
Discussion.-This prospective data suggest that less sedentary behaviour, may 
counteract in part, some of the negative effects of increasing body weight on glucose-insulin 
homeostasis.  
 
Keywords: cardio-metabolic risk, glucose, insulin, insulin resistance, physical activity, 
prospective, sedentary-time 
 
Abbreviations: HOMA-IR: Homeostatic Model Assessment index of Insulin Resistance 
homeostasis 
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Impact d’un comportement sédentaire sur le changement de l’insulino-résistance et 
l’insulino-sécrétion sur trois ans : interaction avec le gain de poids  L’étude RISC. 
 
Objectifs.-La limitation du temps consacré à des occupations sédentaires est de plus en 
plus prise en compte en matière de prévention du diabète et des maladies cardio-vasculaires. 
Cependant, l’association prospective entre comportements sédentaires et/ou l’activité 
physique et les facteurs de risque cardio-métaboliques est mal connue. 
Matériel et méthodes.-Le temps sédentaire et la durée d’activité physique d’intensité 
modérée ou élevée ont été mesurés par accéléromètres chez 313 hommes et 414 femmes, âgés 
de 30 à 60 ans à l’inclusion dans l’étude européenne RISC. De façon concomitante, 
l’insulino-sensitibilité a été quantifiée par clamp euglycémique hyperinsulinémique. Après 
trois ans, les facteurs de risque cardio-métaboliques (anthropométrie, glycémie, insulinémie, 
lipides) ont été remesurés et étaient analysables chez 549 participants de l’étude.  
Résultats.-Les analyses transversales à l’inclusion, après ajustement sur l’âge, le sexe, le 
centre de recrutement et la durée d’activité physique d’intensité modérée ou élevée, 
montraient des associations défavorables entre le temps sédentaire et le poids corporel, le 
cholestérol-HDL, les triglycérides, l’insulino-sensibilité (mesuré par le clamp) et l’insulino-
sécrétion (tous Ptendance<0.002). L’association entre le temps sédentaire et l’insulino-sécrétion 
restait significative après ajustement pour l’insulino-sensibilité (Ptendance=0.02). Les analyses 
longitudinales montraient que plus de temps passé sédentaire était élevé, plus la glycémie et 
l’insulinémie à jeun et l’indice HOMA d’insulino-résistance étaient augmentés, mais ceci 
uniquement chez les individus dont l’IMC augmentait: (de plus de 0.3 kg/m², médiane de sa 
variation sur 3 ans) (tous Ptendance<0.01); ces associations restaient significatives après 
ajustement additionnel sur la durée des activités physiques d’intensité modérée ou élevée. La 
variation sur 3 ans de l’insulino-secretion était plus bas chez ceux qui passaient plus de temps 
dans les activities physique d’intensité modérée ou élevée (Ptrend=0.03).  
Conclusions.-Les données de cette étude prospective suggèrent qu’une limitation du temps 
consacré aux occupations sédentaires pourrait compenser, au moins en partie, les effets 
négatifs d’une augmentation de poids sur l’homéostasie glucidique.  
 
Mots clés : activité physique, comportement sédentaire, glycémie, insulinémie, insulino-
résistance, prospective, risque cardio-métabolique 
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Introduction 
In addition to the well-established role of physical activity for prevention of chronic 
diseases such as type 2 diabetes [1,2], the deleterious impact of sedentary-time is increasingly 
documented [3,4].  In longitudinal studies, mortality and morbidity have been associated with 
sedentary behaviours, such as television viewing [5,6], but this is only part of the time spent 
sedentary [7]. In developed countries, more than 50% of waking time, as measured by 
accelerometry, is sedentary [8-11]. Sedentary-time as recorded by questionnaire is lower, and 
depends not only on the validity and reliability of questionnaires [12] but also on the 
questions asked and the definitions used. In European countries, the prevalence of sedentary-
time, as evaluated by the International Physical Activity Questionnaire (IPAQ) and defined as 
less than 3,000 MET minutes per week accumulated over seven days, ranged from 19% to 
43%; 23% to 56% of people spent > 6 hours per day sitting [13]. Thus in western societies, a 
very large percentage of waking time is spent sedentary. 
While the relations between sedentary-time and morbidity and mortality have been 
extensively studied [3-6], we have identified only three prospective studies with objectively 
measured sedentary-time that investigated its impact on changes in cardio-metabolic risk 
[10,14,15]. Changes in cardio-metabolic risk factors have been studied in relation with 
physical activity documented objectively [16] and by questionnaire [17-22]. 
In contrast, cross-sectional studies have evaluated sedentary-time and cardio-
metabolic risk factors, with sedentary-time evaluated objectively by accelerometry [9,11,23], 
and by questionnaire [24-26]. We have already shown that insulin sensitivity is related with 
total activity, the intensity of activity and with sedentary-time, using cross-sectional data from 
the Relationship between Insulin Sensitivity and Cardiovascular disease (RISC) Study, where 
activity was evaluated by an accelerometer [8]. 
This report studies the 3-year evolution of cardio-metabolic risk factors with 
sedentary-time, in participants from the RISC Study [27].  In parallel we study associations 
with time spent in activities of moderate or vigorous intensity. 
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Research Design and Methods 
RISC is a 3-year observational cohort study aiming to evaluate insulin resistance and 
atherosclerosis development [27]; in 2002-2004, > 1,400 volunteers were recruited in 20 
centres in 13 European countries, aged 30-60 years, without diabetes, hypertension, or 
dyslipidaemia. Each recruitment centre had ethics committee approval for the study, and 
participants gave written informed consent. Examinations included anthropometry, blood 
pressure, blood sampling, oral glucose tolerance test (blood drawn at fasting, 30, 60, 90 and 
120 mins), euglycaemic hyperinsulinaemic clamp. Activity and sedentary behaviours were 
monitored in participants who consented to wear an accelerometer.  All above examinations, 
except for the euglycaemic hyperinsulinaemic clamp and accelerometer monitoring, were 
repeated after three years.  
 
Study Population 
At baseline, among 1259 volunteers with an evaluation of insulin sensitivity, 847 had data 
on physical activity recorded by accelerometry, 777 satisfied study entry criteria, and 727 had 
data on cardio-metabolic parameters. At three years, anthropometry, blood pressure and 
plasma sample data were available for 549 participants. 
 
Methods of measurement of cardio-metabolic risk factors 
Body weight and body composition (fat-free-mass, fat-mass) were measured by 
bipedal bioelectric impedance analysis (TBF300; TANITA International Division, UK) on 
lightly clad participants, height with a clinical stadiometer, waist circumference by tape-
measure horizontally placed mid-way between the lower costal margins and iliac crests on the 
midaxillary line; body-fat (%) = 100*(fat-mass(kg))/body-weight(kg)). Sitting systolic and 
diastolic blood pressures were measured three times by an automated device (OMRON 705cp, 
OMRON Healthcare Europe, Netherlands) and the median used in analyses.  
Biology was assayed centrally [27]. In Odense, Denmark, plasma glucose was 
measured by the glucose oxidase technique (Cobas Integra; Roche), and serum insulin by a 
specific time-resolved fluoroimmunoassay (AutoDELFIA Insulin kit; Wallac Oy, Turku, 
Finland). In Dublin, Ireland, total-cholesterol, HDL-cholesterol and triglycerides were 
measured using colorimetric enzymatic tests (respectively, Roche Cholesterol Method for 
Modular Systems, Roche HDL 2
nd
 Generation Method for Modular Systems, and Roche 
Triglycerides Method for Modular System). LDL-cholesterol concentration was calculated by 
the Friedewald formula.  
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At baseline the hyperinsulinaemic euglycaemic clamp quantified insulin 
sensitivity [27]. The Homeostatic Model Assessment index of insulin resistance HOMA-IR 
was calculated at baseline and three years [28]. 
 Insulin secretion has been quantified at baseline and at three years by:  
Insulin secretion index = (insulin 30min-insulin 0min)/(glucose 30min) [29]. 
Physical activity and sedentary-time were measured objectively by a small single-axis 
accelerometer (Actigraph, AM7164-2.2; Computer Science and Applications, Pensacola, 
FL) [30]. Acceleration signals were digitized by an 8-bit analog to digital converter, sampling 
10 times per second. Each digitized signal was summed over a 1-minute interval and total 
activity (counts per minute) was saved in memory. The accelerometer was secured by a belt at 
the small of the back from waking until going to sleep, except during water-based activities, 
and it was worn for up to eight days. We included only those days when the accelerometer 
was worn for at least 10 hours and only those people with at least three days of recording. 
Non-wearing periods were identified as 60 minutes or more of continuous zero counts. 
Accelerometer data were processed with custom software developed for this project using 
SAS version 9.1 [8].  
Cut-offs were used to define sedentary behavior (<100 counts/min), and activities of 
moderate or vigorous intensity (1952 to 5724 counts/min, and >5724 counts/min, 
respectively) [30,31]. For activity of moderate or vigorous intensity, >10 minutes was 
required, according to recommendations of “bouts lasting 10 minutes or more” [1].  
Two parameters are analyzed in this report: 
- sedentary-time, the time when participants were sedentary; 
- time spent in activities of moderate or vigorous intensity. 
 
Statistical Analyses 
Analyses used SAS (version 9.2). Variables with non-symmetric distributions: triglycerides, 
insulin, insulin sensitivity, HOMA-IR, and the insulin secretion index, were logarithmically 
transformed. Participant characteristics, at baseline and follow-up, are described by means 
(SD), geometric means (x/÷ exp[SD log-transformed data]) or n (%), and compared between 
men and women, or between those followed at three years and those not followed, using t-
tests, ² tests and for the activity variables, Wilcoxon tests. Spearman correlation coefficients 
were calculated. Linear models were used to study both cross-sectional associations and the 
three-year evolution of cardio-metabolic risk factors, in relation with activity variables 
measured at baseline; models were adjusted for age, gender and for recruitment centre 
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(included in models as a random factor). Data from men and women were combined as there 
were very few interactions between gender and activity variables; gender specific results are 
presented where there was a significant interaction.  
To correct for the time that the accelerometer was worn, we analysed residuals from sex-
specific models with time variables regressed on the time the accelerometer was worn [23,32]. 
We have not analysed time spent in light intensity activity (time not sedentary nor in activity 
of moderate or vigorous intensity) as it was highly correlated with sedentary-time (rSpearman=-
0.95, –0.98 in men and women respectively). 
Sedentary-time and time spent in activity of moderate or vigorous intensity were analyzed 
in sex-specific quartile groups, and Ptrend across quartile groups is presented. As 31% of men 
and 34% of women had no activity of moderate or vigorous intensity, this variable and 
sedentary-time are analyzed in classes. In a sensitivity analysis, sedentary-time was analyzed 
as a continuous variable.  
Cross-sectional associations with sedentary-time were further adjusted for time spent in 
activities of moderate or vigorous intensity, and associations with time spent in activity of 
moderate or vigorous intensity were further adjusted for BMI. 
The three-year evolution of all cardio-metabolic risk factors was analysed according to 
baseline sedentary-time and time spent in activities of moderate or vigorous intensity. 
Interactions were sought between sedentary-time and factors which could modify the effect of 
sedentary time: baseline insulin sensitivity, baseline BMI and three-year change in BMI. 
These three factors were divided according to their medians. Significant interactions were 
only observed (P<0.05) between change in BMI (median=+0.3kg/m²) and cardio-metabolic 
risk factor evolution. Sedentary-time analyses were further adjusted on time spent at baseline 
in activities of moderate or vigorous intensity. 
 
Results 
Population description 
The mean age at baseline of the 313 men and 414 women was 43 and 45 years, with 
mean BMI 25.8 and 24.3 kg/m
2
, respectively (Table 1). Gender differences were observed for 
most of the body composition and metabolic variables, and men generally had a more at-risk 
profile than women. In our study population, more than 60% of accelerometer wearing time 
was spent sedentary, and on average, men spent more hours sedentary than women 
(P=0.0007). Men spent marginally more time in activities of moderate or vigorous intensity 
than women (P=0.12). Sedentary-time and time spent in activities of moderate or vigorous 
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intensity, both adjusted for the time the accelerometer was worn, were correlated, with 
Spearman correlation coefficients r=-0.15 for men and r=-0.25 for women (both P<0.007). 
The participants who were followed up at three years, were older than those who did 
not participate (45 vs 41 years, P=0.0001), but there were no differences in other baseline 
variables after age adjustment.  
 
Cross-sectional analysis of sedentary-time and physical activity with cardio-metabolic risk 
factors at baseline 
Sedentary-time was positively associated with body weight (but not with BMI or body 
fat), waist circumference, triglycerides, insulin secretion, and negatively associated with 
insulin sensitivity (as measured by the clamp) and HDL-cholesterol, after adjustment for age, 
gender and recruitment centre (all Ptrend<0.04) (Table 2); these relations were attenuated but 
all remained statistically significant after adjustment for the time spent in activities of 
moderate or vigorous intensity, excepting for waist circumference (Ptrend=0.12). The insulin 
secretion index increased with sedentary-time, and remained significant after additional 
adjustment for clamp measured insulin sensitivity (Ptrend=0.02).   
When sedentary-time was analyzed as a continuous variable rather than in quartiles, 
the relations for higher body weight, triglycerides, insulin secretion, insulin sensitivity, and 
lower HDL-cholesterol, remained significant; further, LDL-cholesterol and 2h-insulin were 
positively and significantly related with sedentary-time (Ptrend=0.04, 0.008 respectively) and 
fasting glucose and fasting insulin both showed a marginal significance (Ptrend=0.056, 0.054 
respectively); waist circumference also showed a marginal association (Ptrend=0.13). 
Supplementary Table 1 shows mean values of cardio-metabolic parameters according 
to quartiles of time spent in activities of moderate or vigorous intensity. The anthropometric 
measures were strongly related with the time spent in these activities (all Ptrend<0.0001), and 
waist circumference remained associated after adjustment for BMI. Blood pressure, heart rate; 
lipids, insulin and insulin sensitivity measured both by the clamp and by the HOMA-IR index 
as well as insulin secretion were associated with the time spent in activities of moderate or 
vigorous intensity (all Ptrend<0.05); glucose concentrations were not associated with these 
activities. After adjusting for BMI, more time spent in activities of moderate or vigorous 
intensity was associated with lower waist circumference, heart rate, total and LDL-
cholesterol, fasting insulin and higher HDL-cholesterol concentrations.  The favorable 
relations seen with blood pressure, triglycerides, insulin sensitivity and insulin secretion were 
no longer significant after accounting for BMI.  
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Prospective analysis of sedentary-time and physical activity with the evolution of cardio-
metabolic risk factors  
 There were no relations between sedentary time or time in activities of moderate or 
vigorous intensity and changes in cardio-metabolic risk factors, and there were no effect 
modifications with baseline BMI or insulin sensitivity, as interactions were all non-significant. 
However for the 3-year change in BMI, there were significant interactions for both activity 
variables, with fasting glucose, fasting insulin and HOMA-IR. In the 50% of participants who 
had an increase in BMI of at least 0.3 kg/m², (median BMI change), baseline sedentary-time 
and the time in activities of moderate or vigorous intensity, were associated with the 
evolutions in fasting glucose, fasting insulin and HOMA-IR (Fig. 1, Supplementary Fig. 1): 
people with sedentary time below the lower quartile had a 0.2 mmol/l lower 3-year change in 
fasting glucose than those above the upper quartile. These three relations with baseline 
sedentary-time remained significant after controlling for time spent in activities of moderate 
or vigorous intensity (all Ptrend<0.05).  
The only other significant association was a smaller 3-year change in insulin secretion 
in those with more time spent in moderate or vigorous activity at baseline (Ptrend=0.03, with 
mean insulin secretion indices in the four quartile groups: 17.8, 14.4, 16.3, and 12.6 
respectively). This association remained significant after adjusting for the 3-year change in 
the HOMA-IR index (Ptrend=0.05), but lost significance when adjusted for baseline insulin 
clamp-evaluated insulin sensitivity (Ptrend=0.55). There was no interaction with the 3-year 
change in BMI (P=0.15).  
At baseline, there were no significant differences in the characteristics of those who 
increased their BMI by at least 0.3 kg/m², and those who did not.  The factor that differed 
most between these two groups was insulin sensitivity, with geometric means of 134 and 
144 mol.min-1.kgFFM
-1
.nmol/l
-1
 respectively (P=0.066)  
 Changes in other cardio-metabolic parameters, (BMI, waist circumference, blood 
pressure, heart rate, total, HDL- and LDL-cholesterol, triglycerides, the post charge values of 
glucose and insulin) were not significantly related with sedentary-time, nor with the time 
spent in activities of moderate or vigorous intensity. 
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Discussion 
Less sedentary-time and more time in activities of moderate or vigorous intensity at 
baseline were associated with smaller increases in fasting glucose, fasting insulin and insulin 
resistance over the 3-year period, but only in those who increased more their BMI.  
In cross-sectional analyses, the time in activities of moderate or vigorous intensity was 
associated with lower values of the anthropometric variables, whereas sedentary-time was 
associated only with a higher body weight, after adjusting for time in activities of moderate or 
vigorous intensity. Sedentary-time was also associated with higher triglycerides, insulin 
sensitivity and secretion and lower HDL-cholesterol, after adjusting for time spent in 
activities of moderate or vigorous intensity.  Insulin secretion was still related with sedentary-
time after additionally adjusting on clamp-measured insulin sensitivity. For participants who 
spent more time in activities of moderate or vigorous intensity, after BMI adjustment, lower 
mean values were recorded for waist circumference, heart rate, total, LDL-cholesterol and 
fasting insulin and higher means for HDL-cholesterol. 
 
Cross sectional relations between cardio-metabolic risk factors and objectively measured 
sedentary-time 
Our cross-sectional results can be compared with studies on sedentary behaviour 
assessed using accelerometry [9,11,15,23]. Of note none of these studies assessed insulin 
sensitivity by the gold-standard clamp method. After accounting for physical activity, a small 
Australian study found that waist, only, was related with sedentary-time [9]; one study in the 
NHANES population showed no relation with the metabolic syndrome [11], yet another 
analysis on a larger NHANES population showed relations with waist circumference, HDL-
cholesterol, triglycerides, insulin, HOMA-IR and the HOMA insulin-secretion index [15]; in a 
study of newly-diagnosed type 2 diabetic patients, associations were found with waist 
circumference, HDL cholesterol, insulin and the HOMA-IR index [23]. 
In our study, body weight (but not BMI nor waist circumference), HDL-cholesterol, 
triglycerides, clamp measured insulin sensitivity (but not HOMA-IR) and insulin secretion 
were all associated with sedentary-time, after adjusting for the time spent in activities of 
moderate or vigorous intensity. These results are in line with other studies, and show the 
advantages of the more precise clamp measure of insulin sensitivity over the HOMA-IR 
index, which was not significantly associated with sedentary-time in the RISC data. 
Furthermore insulin secretion remained associated with sedentary-time after adjustment for 
clamp measured insulin sensitivity. Both insulin sensitivity and insulin secretion are key 
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elements in the progression towards type 2 diabetes, and this association with sedentary-time 
provides a rationale for targeting sedentary behavior in diabetes prevention programs.  
 
Prospective relations between changes in cardio-metabolic risk factors and objectively 
evaluated sedentary-time 
In the Ely study, sedentary-time was measured objectively by heart rate monitoring 
and insulin sensitivity was evaluated by both fasting plasma insulin and the HOMA-IR index 
in 166 men and 210 women followed 5.6 years [10]. Percent time sedentary and percent time 
spent in activities of moderate or vigorous intensity were significantly associated with fasting 
insulin concentrations, but only sedentary-time remained associated after adjustment for 
covariates, in particular baseline fasting insulin.  
In the ProActive trial [14], 81 men and 111 women with a family history of diabetes 
were followed over one year. Physical activity was measured by accelerometery. The HOMA-
IR index and fasting insulin at follow up were only associated with time spent in activities of 
moderate or vigorous intensity but not with sedentary-time. 
The Early Activity in Diabetes study [15], after a follow-up of six months, showed a 
significant relation between sedentary-time and HDL-cholesterol, even after adjustment for 
waist circumference (P=0.003) and there were marginal relations with waist circumference, 
insulin and the HOMA-IR index (all P<0.1); the latter two relations were greatly attenuated 
after adjustment on waist circumference.  
In our study, we found a relation between change in the HOMA-IR index, as well as 
for fasting glucose and insulin, with sedentary-time and with the time spent in activities of 
moderate or vigorous intensity – but only in the half of the population gaining more weight 
over follow-up. Body weight gain over time is recognized as a risk factor for type 2 diabetes 
[33-35] and cardiovascular disease [36], and our results show that less sedentary-time and 
more activity can influence glucose homeostasis. The data reinforce the notion that efforts 
should be directed at limiting time spent in sedentary behavior for maintenance of metabolic 
health over time, independently of physical activity, even though there was no association 
with changes in lipids or blood pressure. 
The 3-year change in insulin secretion was lower in those who spent more time in 
activities of moderate or vigorous intensity – but as might be expected, this relation was no 
longer significant after adjusting on the baseline clamp-based insulin sensitivity, because their 
higher insulin sensitivity required less insulin secretion. 
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Study strengths and limitations 
To our knowledge, this is the first study to report on associations between objectively 
measured sedentary-time and its relation with changes in cardio-metabolic risk factors. We 
were also able to evaluate insulin sensitivity and insulin secretion.  
One of the disadvantages of using accelerometry is that we do not know when people 
are not wearing the accelerometer, and we and others have defined non-wearing periods by an 
arbitrary period of continuous zero counts. Thus, the sedentary-time may be over-evaluated as 
the accelerometer was not being worn, and conversely, excluded time may be very long 
periods of sedentary-time.  
We were not able to follow-up our entire baseline population, however the baseline 
characteristics of participants studied at three years were similar to those not studied.  
A further limitation is that we did not have a second accelerometer recording to 
evaluate changes in activity over the three years, but from the International Physical Activity 
Questionnaire (IPAQ) [13,37] there was little change in total activity in our study population, 
with a mean total MET-minutes per week increase of 5% (P=0.2). 
Our definition of moderate and vigorous activity required bouts of 10 minutes of such 
activities, in accord with recommendations [1]. When we adjusted the prospective relations 
with sedentary time for total physical activity at baseline, the results were attenuated, and 
remained significant only for the change in fasting glucose.  
 
Conclusions 
As summarized by Tremblay [3] “sedentary behaviour, as distinct from lack of 
moderate to vigorous physical activity, has independent and qualitatively different effects on 
human metabolism, physical function, and health outcomes and thus should be treated as a 
separate and unique construct”. In experimental work, sedentary-time has been associated 
with higher lipids (partly mediated by lipoprotein lipase activity) [37], higher glucose and 
insulin resistance (perhaps mediated by muscle glucose transporter (GLUT4) protein 
content) [38].  
 In the RISC free-living population, more than 60% of time was spent sedentary, and 
less than 1% of time in activity of moderate or vigorous intensity - the remaining time was 
spent in “light activities”, which contribute to the total daily physical activity. While 
recommendations to increase activity with moderate intensity activities such as walking are 
important, the promotion of less sedentary behaviour and more light activity is also important. 
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Indeed, the changes in fasting glucose, insulin and the HOMA-IR index were all attenuated 
after adjusting for total activity, but not for activity of a moderate or vigorous intensity.  
The relations we and others have observed are not strong, and the parameters shown to 
have effects have not always been consistent between studies. However, changing the level of 
activity may have an impact on metabolic health if intervention can induce a population shift 
to less sedentary-time. Indeed two recent reviews propose that high quality prospective 
studies using device based measures may provide a better understanding of the impact of 
sedentary-time on health outcomes [39,40]. 
 
In conclusion, these results suggest that less sedentary behaviour and more activities of 
moderate or vigorous intensity may partly counteract some of the negative effects of 
increasing body weight on glucose homeostasis over time. These findings may help target at 
risk groups in health policies aiming to prevent diabetes at the population level. 
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FIGURE LEGEND 
 
Fig. 1 Mean (SE) of 3-year changes in (a) fasting glucose, (b) fasting insulin and (c) the 
HOMA-IR index according to baseline sedentary-time, adjusted for age, gender and clinical 
recruitment centre, according to strata of change in BMI below and above the median change 
of +0.3 kg/m². The RISC study 
 
19/25 
Table 1  
Anthropometric and metabolic characteristics and accelerometer measures of activity: the 
RISC study 
 
Men (n=313) Women (n=414) P-value 
c
 
  
Age (years) 43 ± 9 45 ± 8 0.02 
    
Body weight (kg) 82 ± 12 66 ± 12 <0.0001 
BMI (kg/m
2
) 25.8 ± 3.1 24.3 ± 4.0 <0.0001 
Body fat (%) 21 ± 6 32 ± 7 <0.0001 
Waist circumference (cm) 92 ± 10 80 ± 11 <0.0001 
    
Systolic BP (mmHg) 122 ± 10 113 ± 12 <0.0001 
Diastolic BP (mmHg) 76 ± 7 73 ± 8 <0.0001 
Heart rate (beats/min) 64 ± 9 69 ± 11 <0.0001 
    
Total cholesterol (mmol/l)  4.88 ± 0.85 4.78 ± 0.85 0.10 
HDL-cholesterol (mmol/l)  1.28 ± 0.28 1.61 ± 0.40 <0.0001 
LDL-cholesterol (mmol/l)  3.07 ± 0.77 2.73 ± 0.78 <0.0001 
Triglycerides (mmol/l)
a
 1.05 x/÷ 1.57 0.85 x/÷1.56 <0.0001 
    
Fasting glucose (mmol/l)  5.2 ± 0.5 5.0 ± 0.5 <0.0001 
2h-glucose (mmol/l)  5.6 ± 1.5 5.8 ± 1.5 0.06 
Fasting insulin (pmol/l)
 a
 30 x/÷ 1.67 28 x/÷ 1.69 0.12 
2h-insulin (pmol/l)
 a
 114 x/÷ 2.46 155 x/÷ 2.05 <0.0001 
    
Insulin sensitivity  
              (mol.min-1.kgFFM
-1
.nmol/l
-1
)
 a
  
121 x/÷ 1.63 149 x/÷ 1.50 <0.0001 
HOMA-IR
 a
 6.92 x/÷ 1.73  6.23 x/÷ 1.78 0.01 
    
Insulin secretion index
 a
 25 x/÷ 1.87 25 x/÷ 1.92 0.64 
    
ACCELEROMETER    
Number of days accelerometer worn 6 (5, 7) 6 (5, 7) 0.94 
Wearing time (hours) 92 (72, 105) 87 (70-103) 0.06 
Sedentary-time (hours) 
b
 55 (41, 64) 50 (39-60) 0.0007 
Percent time 62% 59%  
Moderate or vigorous intensity activity  
                                                  (hours) 
b
 
0.6 (0.0-1.8) 0.4 (0.0, 1.4) 0.12 
Percent time  1% 1%  
No moderate or vigorous intensity 
activity, but not sedentary (hours) 
30 (22, 39) 34 (25, 41) 0.02 
Percent time 37% 40%  
 
Data shown are n (%), means ± SD, or geometric means x/÷ (exponent of SD of the log 
transformed variable) or for the ACCELEROMETER variables median (lower quartile, upper 
quartile) or %. 
a
 Logarithsm taken for comparing geometric means.  
b
 Sedentary: <100 counts/min; Moderate or vigorous intensity activity: ≥10 consecutive mins 
with > 1,952counts/min.  
c 
t-tests for continuous variables, ² test for categorical variables, Wilcoxon tests for 
ACCELEROMETER variables 
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Table 2  
Cardio-metabolic risk factors, means (SE) or geometric means [SE]
 a
, according to quartiles of time spent sedentary at baseline adjusted for the time 
the accelerometer was worn; means are adjusted for age, gender and recruitment centre; Ptrend values are adjusted for age, gender and recruitment 
centre and additionally for time spent in activities of moderate or vigorous intensity. The RISC Study 
 Sedentary-Time 
Ptrend 
 Quartile 1 Quartile 2 Quartile 3 Quartile 4 
Men (n=313) < 50.4 hrs 50.4-56.9 hrs 57.0-61.8 hrs ≥ 62 hrs Adjusted:  
age, sex, 
centre  
Adjusted:  
age, sex, 
centre, 
mod/vig 
activity  
 n=78 n=79 n=78 n=78 
     
Women (n=414) < 45.9 hrs 45.9-51.5 hrs 51.6-57.3 hrs ≥ 57.4 hrs 
 n=103 n=104 n=104 n=103 
Body weight (kg) 71 (1.10) 71 (1.09) 74 (1.11) 74 (1.10) 0.002 0.006 
BMI (kg/m
2
) 25.0 (0.30) 24.4 (0.30) 25.2 (0.30) 25.2 (0.30) 0.21 0.43 
Body fat (%) 27 (0.59) 26 (0.58) 27 (0.59) 27 (0.59) 0.26 0.59 
Waist circumference (cm) 85 (1.07) 84 (1.07) 86 (1.09) 86 (1.08) 0.04 0.12 
       
Systolic BP (mmHg) 116 (1.09) 116 (1.09) 117 (1.11) 117 (1.10) 0.35 0.48 
Diastolic BP (mmHg) 73 (0.72) 74 (0.71) 74 (0.73) 74 (0.72) 0.44 0.59 
Heart rate (beats/min) 67 (1.23) 67 (1.23) 66 (1.24) 67 (1.24) 0.70 0.33 
       
Total cholesterol (mmol/l) 4.72 (0.08) 4.76 (0.08) 4.87 (0.08) 4.77 (0.08) 0.30 0.59 
HDL-cholesterol (mmol/l) 1.51 (0.03) 1.51 (0.03) 1.43 (0.03) 1.41 (0.03) 0.002 0.007 
LDL-cholesterol (mmol/l) 2.78 (0.08) 2.82 (0.08) 2.95 (0.08) 2.85 (0.08) 0.13 0.36 
Triglycerides (mmol/l)
 a
 0.85 [1.04] 0.89 [1.04] 0.94 [1.04] 0.99 [1.04] 0.0004 0.003 
       
Fasting  glucose (mmol/l) 5.06 (0.06) 5.06 (0.06) 5.03 (0.06) 5.01 (0.06) 0.31 0.29 
2h-glucose (mmol/l) 5.67 (0.16) 5.73 (0.15) 5.46 (0.16) 5.78 (0.16) 0.99 0.98 
Fasting insulin (pmol/l)
 a
 27 [1.05] 28 [1.05] 29 [1.05] 29 [1.05] 0.12 0.28 
2h-insulin (pmol/l)
 a
 120 [1.09] 129 [1.09] 132 [1.09] 138 [1.09] 0.08 0.13 
       
Insulin sensitivity  
               (µmol.min
-1
.kgFFM
-1
.nmol/l
-1
)
 a
 
146 [1.05] 134 [1.05] 131 [1.05] 122 [1.05] 
0.0001 0.0005 
HOMA-IR
a
 6.11 [1.05] 6.30 [1.05] 6.50 [1.05] 6.54 [1.05] 0.20 0.42 
Insulin secretion index
a
 23 [1.06] 23 [1.06] 27 [1.06] 27 [1.06] 0.001 0.002 
a
  geometric means [SE] 
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-0.2
0.0
0.2
0.4
≥ 0.3 kg/m²; slope = 0.094, P=0.0004
< 0.3 kg/m²; slope =  -0.026, P=0.39
interaction P = 0.0004
3 year change in BMI
Q1 Q2                  Q3                 Q4
3-year change in
fasting glucose (mmol/l)
A
quartiles of sedentary time
 
-10.0
-5.0
0.0
5.0
10.0
15.0
≥ 0.3 kg/m²; slope =2.74, P=0.01
< 0.3 kg/m²; slope =  -1.50, P=0.11
interaction P = 0.02
3 year change in BMI
Q1 Q2                   Q3                  Q4
3-year change in
fasting insulin (pmol/l)
B
quartiles of sedentary time
 
-4.0
-3.0
-2.0
-1.0
0.0
1.0
2.0
3.0
4.0
≥ 0.3 kg/m²; slope = 0.803, P=0.006
< 0.3 kg/m²; slope =  -0.425, P=0.08
interaction P = 0.006
3 year change in BMI
Q1 Q2                  Q3                 Q4
3-year change in
HOMA-IR
C
quartiles of sedentary time
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Supplementary Table 1 
Cardio-metabolic risk factors, means (SE) or geometric means [SE]
a
, according to quartiles of time spent in activities of moderate or vigorous 
intensity at baseline, adjusted for the time the accelerometer was worn; means are adjusted for age and recruitment centre; Ptrend values are adjusted 
for age, gender, recruitment centre and additionally for BMI. The RISC Study 
 Time Spent in Moderate or Vigorous Activity 
Ptrend  Quartile 1 Quartile 2 Quartile 3 Quartile 4 
Men (n=313) < 0.12 hrs 0.12–0.65 hrs 0.66-1.73 hours ≥ 1.74 hrs Adjusted: 
age,  
centre  
Adjusted: 
age, 
centre, 
BMI  
 n=80 n=77 n=77 n=79 
     
Women (n=414) < 0.09 hrs 0.09–0.39 hrs 0.40-1.39 hrs ≥ 1.40 hrs 
 n=104 n=103 n=103 n=104 
Body weight (kg) 76 (1.11) 73 (1.10) 72 (1.10) 70 (1.12) 0.0001  
BMI (kg/m
2
) 25.8 (0.30) 25.1 (0.30)  24.8 (0.30) 24.1 (0.30) 0.0001  
Body fat (%) 28 (0.61) 27 (0.61) 26 (0.60) 25 (0.62) 0.0001  
Waist circumference (cm) 88 (1.08) 86 (1.07) 85 (1.06) 83 (1.09) 0.0001 0.03 
       
Systolic BP (mmHg) 118 (1.09) 118 (1.08) 115 (1.08) 116 (1.10) 0.04 0.30 
Diastolic BP (mmHg) 75 (0.74) 74 (0.73) 73 (0.73) 73 (0.75) 0.02 0.22 
Heart rate (beats/min) 68 (1.22) 68 (1.22) 67 (1.21) 64 (1.23) 0.0002 0.002 
       
Total cholesterol (mmol/l) 4.92 (0.08) 4.73 (0.08) 4.78 (0.08) 4.66 (0.08) 0.007 0.03 
HDL-cholesterol (mmol/l) 1.42 (0.03) 1.44 (0.03) 1.44 (0.03) 1.55 (0.03) 0.001 0.05 
LDL-cholesterol (mmol/l) 3.01 (0.08) 2.80 (0.08) 2.86 (0.08) 2.70 (0.08) 0.0005 0.006 
Triglycerides (mmol/l)
 a
 0.96 [1.04] 0.95 [1.04] 0.93 [1.06] 0.83 [1.06] 0.003 0.12 
       
Fasting  glucose (mmol/l) 5.05 (0.06) 5.09 (0.06) 5.01 (0.06) 5.03 (0.06) 0.38 0.83 
2h-glucose (mmol/l) 5.71 (0.15) 5.57 (0.15) 5.64 (0.15) 5.76 (0.16) 0.64 0.14 
Fasting insulin (pmol/l)
 a
 31 [1.05] 30 [1.05] 28 [1.05] 25 [1.05] 0.0001 0.03 
2h-insulin (pmol/l)
 a
 140 [1.09] 131 [1.09] 131 [1.09] 119 [1.09] 0.06 0.61 
       
Insulin sensitivity
 a 
      
(µmol.min
-1
.kgFFM
-1
.nmol/l
-1
)            Men 105 [1.07] 124 [1.07] 114 [1.07] 129 [1.07] 0.03 0.27 
Women 140 [1.05] 135 [1.05] 156 [1.05] 159 [1.07] 0.004 0.12 
HOMA-IR
 a
                                              Men 7.24 [1.07] 7.20 [1.07] 6.95 [1.07] 5.97 [1.07] 0.03 0.37 
Women 6.82 [1.07] 6.53 [1.07] 5.74 [1.07] 5.39 [1.07] 0.001 0.11 
Insulin secretion index
 a
 25.1 [1.06] 25.1 [1.06] 27.0 [1.06] 22.1 [1.06] 0.05 0.38 
a
  geometric means [SE] 
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Supp Fig. 1 Mean (SE) of 3-year changes in (a) fasting glucose, (b) fasting insulin and (c) the HOMA-IR 
index according to baseline of time spent in moderate or vigorous activity, adjusted for age, gender and 
clinical recruitment centre, according to strata of change in BMI below and above the median change of 
+0.3 kg/m². The RISC study 
 
-0.2
0.0
0.2
0.4
≥ 0.3 kg/m²; slope = -0.048, P=0.08
< 0.3 kg/m²; slope =  0.018, P=0.56
interaction  P = 0.0004
3 year change in BMI
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3-year change in
fasting glucose (mmol/l)
a
quartiles of time spent in moderate or vigorous activity
 
-10.0
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0.0
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≥ 0.3 kg/m²; slope =-2.93, P=0.009
< 0.3 kg/m²; slope =  0.713, P=0.45
interaction  P = 0.005
3 year change in BMI
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3-year change in
fasting insulin (pmol/l)
b
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< 0.3 kg/m²; slope =  0.231, P=0.33
interaction  P = 0.006
3 year change in BMI
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c
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